SCHEMBL15613189

SCHEMBL15613189

CCN(CC)CCCn1c(=S)[nH]c2cc(C(=O)OC)ccc2c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 1.00
▸ PKM P14618 1/20 0.72
▸ MEN1 O00255 2/20 0.71
▸ KMT2A Q03164 2/20 0.71
▸ HPGD P15428 4/20 0.70
▸ SMN1; SMN2 Q16637 4/20 0.70
▸ KDM4E B2RXH2 1/20 0.70
▸ HTT P42858 1/20 0.70
▸ TDP1 Q9NUW8 1/20 0.70
▸ RECQL P46063 2/20 0.67
▸ GAA P10253 1/20 0.66
▸ L3MBTL1 Q9Y468 1/20 0.60
▸ TSHR P16473 2/20 0.58
▸ MAPT P10636 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16872898 0.89 ALDH1A1 (0.80) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL19665251 0.78 MPO (0.67) ALDH1A1PKMMEN1KMT2AHPGD
SCHEMBL2730985 0.74 KMT2A (0.67) ALDH1A1PKMMEN1KMT2AHPGD
SCHEMBL2731359 0.74 KMT2A (0.70) ALDH1A1PKMMEN1KMT2AHPGD
SCHEMBL30414309 0.74 KMT2A (0.77) ALDH1A1PKMMEN1KMT2AHPGD
SCHEMBL6306378 0.74 KMT2A (0.77) ALDH1A1PKMMEN1KMT2AHPGD
SCHEMBL5652363 0.74 SMN1; SMN2 (0.76) ALDH1A1KMT2AHPGDSMN1; SMN2KDM4E
SCHEMBL15506189 0.71 GAA (0.65) ALDH1A1MEN1KMT2AHPGDSMN1; SMN2
SCHEMBL2731374 0.70 MPO (1.00) ALDH1A1MEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL2117984 0.70 ALDH1A1 (0.69) ALDH1A1PKMMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170348295-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA SIRGA ADVANCED BIOPHARMA INC (US) 2017-12-07 — — US disclosed
US-20170348295-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA SIRGA ADVANCED BIOPHARMA INC (US) 2017-12-07 — — US disclosed
US-9775835-B2 Small molecule inhibitors of viral protein interactions with human t-RNA SIRGA ADVANCED BIOPHARMA, INC. (US) 2017-10-03 — — US disclosed
US-9775835-B2 Small molecule inhibitors of viral protein interactions with human t-RNA SIRGA ADVANCED BIOPHARMA, INC. (US) 2017-10-03 — — US disclosed
US-20150190384-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA SIRGA ADVANCED BIOPHARMA, INC. (US) 2015-07-09 — — US disclosed
US-20150190384-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA SIRGA ADVANCED BIOPHARMA, INC. (US) 2015-07-09 — — US disclosed
WO-2014025749-A2 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA SIRGA ADVANCED BIOPHARMA, INC. (US) 2014-02-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170348295-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA NSUN3, TARBP1, TRDMT1 ALDH1A1 4756/4885PKM 4022/4885MEN1 3917/4885
US-20150190384-A1 SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA NSUN3, TARBP1, TRDMT1 ALDH1A1 4753/4885PKM 4051/4885MEN1 3866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback